ClouDr Group Past Earnings Performance

Past criteria checks 0/6

ClouDr Group has been growing earnings at an average annual rate of 3.2%, while the Healthcare industry saw earnings growing at 5.1% annually. Revenues have been growing at an average rate of 34.8% per year.

Key information

3.2%

Earnings growth rate

16.1%

EPS growth rate

Healthcare Industry Growth11.3%
Revenue growth rate34.8%
Return on equity-18.5%
Net Margin-8.8%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely

Apr 24
Cautious Investors Not Rewarding ClouDr Group Limited's (HKG:9955) Performance Completely

ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward

Apr 17
ClouDr Group Limited (HKG:9955) Soars 67% But It's A Story Of Risk Vs Reward

ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate

Feb 20
ClouDr Group Limited (HKG:9955) Shares Could Be 36% Below Their Intrinsic Value Estimate

An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued

Oct 07
An Intrinsic Calculation For ClouDr Group Limited (HKG:9955) Suggests It's 29% Undervalued

Revenue & Expenses Breakdown

How ClouDr Group makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:9955 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233,691-3231,17988
30 Sep 233,551-4691,26282
30 Jun 233,411-6141,34576
31 Mar 233,199-1,1521,32795
31 Dec 222,988-1,6891,308115
30 Sep 222,738-1,8871,277168
30 Jun 222,430-2,8441,186207
31 Mar 222,093-3,4921,123222
31 Dec 211,757-4,1391,060236
30 Sep 211,513-4,7011,134227
31 Dec 20839-2,867943132
31 Dec 19524-55722424
31 Dec 18250-14010519

Quality Earnings: 9955 is currently unprofitable.

Growing Profit Margin: 9955 is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 9955 is unprofitable, but has reduced losses over the past 5 years at a rate of 3.2% per year.

Accelerating Growth: Unable to compare 9955's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 9955 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.2%).


Return on Equity

High ROE: 9955 has a negative Return on Equity (-18.54%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.